NEURALSTEM
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.
NEURALSTEM
Industry:
Biotechnology Health Care Neuroscience Therapeutics
Founded:
1996-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.neuralstem.com
Total Employee:
11+
Status:
Active
Contact:
+30136649606
Total Funding:
39.86 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache ReCAPTCHA ReCAPTCHA V2 AdBlock Acceptable Ads Amazon Ireland Region Symantec Secure Site ASP.NET 2.0 Confluence Networks
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Stock Details
Investors List
Tianjin Pharmaceutical Group International Holdings
Tianjin Pharmaceutical Group International Holdings investment in Post-IPO Equity - NeuralStem
Hercules Capital
Hercules Capital investment in Post-IPO Debt - NeuralStem
Official Site Inspections
http://www.neuralstem.com
- Host name: 104.21.71.116
- IP address: 104.21.71.116
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeuralStem"
Neuralstem, Inc. - Wikipedia
Neuralstem Inc. is a biotechnology company headquartered in Rockville, Maryland that specializes in developing commercial-scale production of multiple types of central nervous system stem cells. In October 2019 Neuralstem announces that the company has changed its name to Seneca Biopharma, Inc. In April 2021 Seneca Biopharma merged with Leading BioSciences to form the combined company Palisade Bio, Inc. See details»
NeuralStem - Crunchbase Company Profile & Funding
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, …See details»
Neuralstem, Inc. - LinkedIn
Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation...See details»
Neuralstem - Investors - Corporate Governance
The reputation of Neuralstem as a fair, reputable and honest organization can only be maintained if all of its employees, officers and directors adhere to high moral and ethical standards in …See details»
Neuralstem Becomes Seneca Biopharma - PR Newswire
Oct 28, 2019 · Seneca Biopharma, Inc., is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets,...See details»
Neuralstem, Inc. - Company Profile & Staff Directory - ContactOut
Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of …See details»
Neuralstem Inc. Company Profile | StatInvestor
Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem …See details»
Neuralstem, Inc. - Wikiwand
Neuralstem Inc. is a biotechnology company headquartered in Rockville, Maryland that specializes in developing commercial-scale production of multiple types of central nervous …See details»
NeuralStem - Funding, Financials, Valuation & Investors
Neuralstem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.See details»
Neuralstem Announces Plan of Reorganization to Further Align …
May 20, 2016 · Neuralstem's patented technology enables the commercial-scale production of multiple types of central nervous system stem cells, which are being developed as potential …See details»
NeuralStem Inc. Obtains University of California, San Diego
Nov 20, 2007 · Neuralstem's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and …See details»
NeuralStem - VentureRadar
Neuralstem is a clinical-stage biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need.See details»
Cell therapy for neurological disorders | Nature Medicine
Oct 15, 2024 · With all the remarkable new approaches to treat neurological disorders, we take a critical look at the state of current clinical trials and how challenges may be overcome with the …See details»
Neural Stem Cells: Generating and Regenerating the Brain - Cell …
Stem cells afford the plasticity to generate, repair, and change nervous system function. Combined with reprogramming technology, human somatic cell-derived NSCs and their …See details»
Neuralstem Phase II Stem Cell Trial Appears Safe
The transplantation of human spinal cord-derived neural stem cells (HSSCs) into the ventral horn of the spinal cord has been shown to delay the onset of ALS and improve animal survival in …See details»
Neuralstem’s Beijing-based Stroke Trial Receives Approval
Sep 28, 2012 · The Rockville, Md-based biopharmceutical company Neuralstem, Inc recently received approval to begin its clinical trial to treat motor deficits as a result of ischemic stroke …See details»
Neuralstem - YouTube
Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of...See details»
Neural stem cells: ready for therapeutic applications? - PMC
In this review, we focus on the biological properties of NSCs and discuss how these cells may be exploited to provide effective therapies for neurological disorders. We also review and discuss …See details»
Stable Intracerebral Transplantation of Neural Stem …
Jun 26, 2019 · NSI-566 is a stable, primary adherent neural stem cell line derived from a single human fetal spinal cord and expanded epigenetically with no genetic modification. This cell line is being tested in clinical trials in the U.S. for …See details»
CRISPR–Cas9 screens reveal regulators of ageing in neural
Oct 2, 2024 · Here we develop in vitro and in vivo high-throughput CRISPR–Cas9 screening platforms to systematically uncover gene knockouts that boost NSC activation in old mice. Our …See details»